The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain
Secreted frizzled related proteins (SFRPs) are a family of Wnt regulators which are frequently downregulated in cancers. In malignant mesothelioma (MM), downregulation of SFRP4 has been reported as a mechanism which contributes to aberrant activation of oncogenic Wnt signaling. Here we investigated...
| Main Authors: | Perumal, Vanathi, Dharmarajan, Arunasalam, Fox, Simon |
|---|---|
| Format: | Journal Article |
| Published: |
Spandidos Publications
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/54197 |
Similar Items
Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
by: Bhuvanalakshmi, G., et al.
Published: (2019)
by: Bhuvanalakshmi, G., et al.
Published: (2019)
Wnt antagonist, secreted frizzled-related protein 4 (SFRP4) and peptides from its associated domains, increases chemotherapeutic response of cancer stem cells of malignant mesothelioma cell lines
by: Perumal, V., et al.
Published: (2017)
by: Perumal, V., et al.
Published: (2017)
Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)
by: Fox, Simon, et al.
Published: (2013)
Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a
by: Perumal, V., et al.
Published: (2015)
by: Perumal, V., et al.
Published: (2015)
SFRP-4 abrogates Wnt-3a-induced ß-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation
by: Constantinou, T., et al.
Published: (2008)
by: Constantinou, T., et al.
Published: (2008)
Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)
by: Richards, Alexander S.K.
Published: (2016)
SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
by: Warrier, Sudha, et al.
Published: (2016)
by: Warrier, Sudha, et al.
Published: (2016)
Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
by: Warrier, S., et al.
Published: (2014)
by: Warrier, S., et al.
Published: (2014)
The role of the cysteine-rich domain and netrin-like domain of secreted frizzled-related protein 4 in angiogenesis inhibition in vitro
by: Longman, D., et al.
Published: (2012)
by: Longman, D., et al.
Published: (2012)
Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
by: Perumal, Vanathi, et al.
Published: (2015)
by: Perumal, Vanathi, et al.
Published: (2015)
Multi-lineage differentiation of mesenchymal stem cells - To Wnt, or not Wnt
by: Visweswaran, Malini, et al.
Published: (2015)
by: Visweswaran, Malini, et al.
Published: (2015)
The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines
by: Visweswaran, M., et al.
Published: (2017)
by: Visweswaran, M., et al.
Published: (2017)
Role of Wnt signalling in early pregnancy
by: Nayeem, S., et al.
Published: (2015)
by: Nayeem, S., et al.
Published: (2015)
Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt ß-catenin signaling via the Wnt antagonist secreted frizzled related protein-4
by: Bhuvanalakshmi, G., et al.
Published: (2017)
by: Bhuvanalakshmi, G., et al.
Published: (2017)
Structure-based prediction of Wnt binding affinities for Frizzled-type cysteine-rich domain
by: Agostino, M., et al.
Published: (2017)
by: Agostino, M., et al.
Published: (2017)
The Influence of Breast Tumour-Derived Factors and Wnt Antagonism on the Transformation of Adipose-Derived Mesenchymal Stem Cells into Tumour-Associated Fibroblasts
by: Visweswaran, M., et al.
Published: (2018)
by: Visweswaran, M., et al.
Published: (2018)
The role of Wnt signalling in angiogenesis
by: Olsen, J., et al.
Published: (2017)
by: Olsen, J., et al.
Published: (2017)
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition
by: Warrier, Sudha, et al.
Published: (2014)
by: Warrier, Sudha, et al.
Published: (2014)
Epigenetic demthylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
by: Deshmukh, A., et al.
Published: (2019)
by: Deshmukh, A., et al.
Published: (2019)
Wnt signaling in triple-negative breast cancer
by: Pohl, S., et al.
Published: (2017)
by: Pohl, S., et al.
Published: (2017)
Expression Profile of Wnt/β-Catenin Signalling Molecules and the Wnt Antagonist Secreted Frizzled-Related Protein 4 in Apoptosis in Breast Cancer Tissue Micro-Arrays
by: Berry, A., et al.
Published: (2014)
by: Berry, A., et al.
Published: (2014)
The role of the sFRP4 protein in modulation of cancer growth and anti-neoplastic drug sensitivity
by: Perumal, Vanathi
Published: (2014)
by: Perumal, Vanathi
Published: (2014)
Paracrine communication modulates production of Wnt antagonists and COX1-mediated prostaglandins in a decidual-trophoblast co-culture model
by: Nayeem, S., et al.
Published: (2015)
by: Nayeem, S., et al.
Published: (2015)
Wnt/ß-Catenin Signalling during Liver Metabolism, Chronic Liver Disease and Hepatocarcinogenesis
by: Shirolkar, Gayatri, et al.
Published: (2018)
by: Shirolkar, Gayatri, et al.
Published: (2018)
The Wnt signaling pathways and cell adhesion
by: Amin, N., et al.
Published: (2012)
by: Amin, N., et al.
Published: (2012)
‘Lnc’-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling
by: Ong, M., et al.
Published: (2017)
by: Ong, M., et al.
Published: (2017)
Wnt signalling in gastrointestinal epithelial stem cells
by: Flanagan, D., et al.
Published: (2018)
by: Flanagan, D., et al.
Published: (2018)
Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators
by: Bhuvanalakshmi, G., et al.
Published: (2017)
by: Bhuvanalakshmi, G., et al.
Published: (2017)
Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan–dextran sulfate nanoparticles enhances their expression and anti-cancer effects
by: Perumal, Vanathi, et al.
Published: (2017)
by: Perumal, Vanathi, et al.
Published: (2017)
In vivo Wnt signaling tracing through a transgenic biosensor fish reveals novel activity domains
by: Moro, E., et al.
Published: (2012)
by: Moro, E., et al.
Published: (2012)
Wnt Signaling Pathway Related Genes In Hepatocellular Carcinoma
by: Ban, Kechen
Published: (2002)
by: Ban, Kechen
Published: (2002)
Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: Role of inhibitor of apoptosis proteins (IAPs) and caspases
by: Cregan, I., et al.
Published: (2013)
by: Cregan, I., et al.
Published: (2013)
Wnt antagonist secreted frizzled-related protein 4 upregulates adipogenic differentiation in human adipose tissue-derived mesenchymal stem cells
by: Visweswaran, Malini, et al.
Published: (2015)
by: Visweswaran, Malini, et al.
Published: (2015)
Brewers’ rice induces apoptosis in azoxymethane-induced colon carcinogenesis in rats via suppression of cell proliferation and the Wnt signaling pathway
by: Tan, Bee Ling, et al.
Published: (2014)
by: Tan, Bee Ling, et al.
Published: (2014)
Mutations in WNT1 cause different forms of bone fragility
by: Keupp, K., et al.
Published: (2013)
by: Keupp, K., et al.
Published: (2013)
Wnt is necessary for mesenchymal to epithelial transition in colorectal cancer cells
by: Schwab, R., et al.
Published: (2017)
by: Schwab, R., et al.
Published: (2017)
Overexpression of WNT2 and TSG101 genes in colorectal
carcinoma
by: Ma, Xiang Ru, et al.
Published: (2008)
by: Ma, Xiang Ru, et al.
Published: (2008)
Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer
by: Coombs, G., et al.
Published: (2012)
by: Coombs, G., et al.
Published: (2012)
The Central Role of Wnt Signaling and Organoid Technology in Personalizing Anticancer Therapy
by: Vincan, Elizabeth, et al.
Published: (2017)
by: Vincan, Elizabeth, et al.
Published: (2017)
Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1
by: Sim, Edmund U. H., et al.
Published: (2002)
by: Sim, Edmund U. H., et al.
Published: (2002)
Similar Items
-
Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
by: Bhuvanalakshmi, G., et al.
Published: (2019) -
Wnt antagonist, secreted frizzled-related protein 4 (SFRP4) and peptides from its associated domains, increases chemotherapeutic response of cancer stem cells of malignant mesothelioma cell lines
by: Perumal, V., et al.
Published: (2017) -
Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013) -
Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a
by: Perumal, V., et al.
Published: (2015) -
SFRP-4 abrogates Wnt-3a-induced ß-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation
by: Constantinou, T., et al.
Published: (2008)